Missing/wrong data?
Log in to edit
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
scientific article published on 21 May 2013
Author/s
author: Floriana Morgillo, Ferdinando Carlo Sasso, Teresa Troiani, Michele Orditura, Raffaele De Palma, Fortunato Ciardiello
Work details
Publication date
May 21, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.